Cargando…
Basal Cell Carcinoma: 10 Years of Experience
Introduction. Basal cell carcinoma (BCC) is a locally invasive malignant epidermal tumour. Incidence is increasing by 10% per year; incidence of metastases is minimal, but relapses are frequent (40%–50%). The complete excision of the BCC allows reduction of relapse. Materials and Methods. The study...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995901/ https://www.ncbi.nlm.nih.gov/pubmed/21151696 http://dx.doi.org/10.1155/2011/476362 |
_version_ | 1782193125100355584 |
---|---|
author | Cigna, Emanuele Tarallo, Mauro Maruccia, Michele Sorvillo, Valentina Pollastrini, Alessia Scuderi, Nicolò |
author_facet | Cigna, Emanuele Tarallo, Mauro Maruccia, Michele Sorvillo, Valentina Pollastrini, Alessia Scuderi, Nicolò |
author_sort | Cigna, Emanuele |
collection | PubMed |
description | Introduction. Basal cell carcinoma (BCC) is a locally invasive malignant epidermal tumour. Incidence is increasing by 10% per year; incidence of metastases is minimal, but relapses are frequent (40%–50%). The complete excision of the BCC allows reduction of relapse. Materials and Methods. The study cohort consists of 1123 patients underwent surgery for basal cell carcinoma between 1999 and 2009. Patient and tumor characteristics recorded are: age; gender; localization (head and neck, trunk, and upper and lower extremities), tumor size, excisional margins adopted, and relapses. Results. The study considered a group of 1123 patients affected by basal cell carcinoma. Relapses occurred in 30 cases (2,67%), 27 out of 30 relapses occurred in noble areas, where peripheral margin was <3 mm. Incompletely excised basal cell carcinoma occurred in 21 patients (1,87%) and were treated with an additional excision. Discussion. Although guidelines indicate 3 mm peripheral margin of excision in BCC <2 cm, in our experience, a margin of less than 5 mm results in a high risk of incomplete excisions. |
format | Text |
id | pubmed-2995901 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-29959012010-12-13 Basal Cell Carcinoma: 10 Years of Experience Cigna, Emanuele Tarallo, Mauro Maruccia, Michele Sorvillo, Valentina Pollastrini, Alessia Scuderi, Nicolò J Skin Cancer Clinical Study Introduction. Basal cell carcinoma (BCC) is a locally invasive malignant epidermal tumour. Incidence is increasing by 10% per year; incidence of metastases is minimal, but relapses are frequent (40%–50%). The complete excision of the BCC allows reduction of relapse. Materials and Methods. The study cohort consists of 1123 patients underwent surgery for basal cell carcinoma between 1999 and 2009. Patient and tumor characteristics recorded are: age; gender; localization (head and neck, trunk, and upper and lower extremities), tumor size, excisional margins adopted, and relapses. Results. The study considered a group of 1123 patients affected by basal cell carcinoma. Relapses occurred in 30 cases (2,67%), 27 out of 30 relapses occurred in noble areas, where peripheral margin was <3 mm. Incompletely excised basal cell carcinoma occurred in 21 patients (1,87%) and were treated with an additional excision. Discussion. Although guidelines indicate 3 mm peripheral margin of excision in BCC <2 cm, in our experience, a margin of less than 5 mm results in a high risk of incomplete excisions. Hindawi Publishing Corporation 2011 2010-12-01 /pmc/articles/PMC2995901/ /pubmed/21151696 http://dx.doi.org/10.1155/2011/476362 Text en Copyright © 2011 Emanuele Cigna et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Cigna, Emanuele Tarallo, Mauro Maruccia, Michele Sorvillo, Valentina Pollastrini, Alessia Scuderi, Nicolò Basal Cell Carcinoma: 10 Years of Experience |
title | Basal Cell Carcinoma: 10 Years of Experience |
title_full | Basal Cell Carcinoma: 10 Years of Experience |
title_fullStr | Basal Cell Carcinoma: 10 Years of Experience |
title_full_unstemmed | Basal Cell Carcinoma: 10 Years of Experience |
title_short | Basal Cell Carcinoma: 10 Years of Experience |
title_sort | basal cell carcinoma: 10 years of experience |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995901/ https://www.ncbi.nlm.nih.gov/pubmed/21151696 http://dx.doi.org/10.1155/2011/476362 |
work_keys_str_mv | AT cignaemanuele basalcellcarcinoma10yearsofexperience AT tarallomauro basalcellcarcinoma10yearsofexperience AT marucciamichele basalcellcarcinoma10yearsofexperience AT sorvillovalentina basalcellcarcinoma10yearsofexperience AT pollastrinialessia basalcellcarcinoma10yearsofexperience AT scuderinicolo basalcellcarcinoma10yearsofexperience |